BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11233545)

  • 21. Sources of radiochemical impurities in the 99mTc/S-unprotected MAG3 system.
    Noll B; Johannsen B; Spies H
    Nucl Med Biol; 1995 Nov; 22(8):1057-62. PubMed ID: 8998467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
    Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
    J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technetium-99m radiopharmaceutical preparation problems: 12 years of experience.
    Ponto JA
    J Nucl Med Technol; 1998 Dec; 26(4):262-4. PubMed ID: 9884939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of Storage Temperature on Radiochemical Purity of
    Uccelli L; Boschi A; Martini P; Cittanti C; Bertelli S; Bortolotti D; Govoni E; Lodi L; Romani S; Zaccaria S; Zappaterra E; Farina D; Rizzo C; Giganti M; Bartolomei M
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29543722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 99Tc on the radiochemical purity of 99mTc radiopharmaceuticals.
    Waight LA; Cunnane CM; O'Brien LM; Millar AM
    Nucl Med Commun; 2011 Aug; 32(8):752-6. PubMed ID: 21597394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radio-UHPLC: a tool for rapidly determining the radiochemical purity of technetium-99m radiopharmaceuticals?
    Kryza D; Janier M
    Appl Radiat Isot; 2013 Aug; 78():72-6. PubMed ID: 23681064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation, radiochemical purity control and stability of 99mTc-mertiatide (Mag-3).
    van Hemert FJ; van Lenthe H; Schimmel KJ; van Eck-Smit BL
    Ann Nucl Med; 2005 Jun; 19(4):345-9. PubMed ID: 16097648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved synthesis and biological evaluation of Tc-99m radiolabeled AMO for miRNA imaging in tumor xenografts.
    Kang L; Fan Z; Sun H; Feng Y; Ma C; Yan P; Zhang C; Ma H; Hao P; Chen X; Zheng Z; Xu X; Wang R
    J Labelled Comp Radiopharm; 2015; 58(13-14):461-8. PubMed ID: 26503645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.
    Vanderheyden JL; Liu G; He J; Patel B; Tait JF; Hnatowich DJ
    Nucl Med Biol; 2006 Jan; 33(1):135-44. PubMed ID: 16459269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple two-strip method to determine the radiochemical purity of technetium-99m mercaptoacetyltriglycine.
    Chen F; Decristoforo C; Rohrbacher B; Riccabona G
    Eur J Nucl Med; 1993 Apr; 20(4):334-8. PubMed ID: 8491226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the hepatobiliary excretion of technetium-99m-MAG3 and reconstitution factors affecting radiochemical purity.
    Shattuck LA; Eshima D; Taylor AT; Anderson TL; Graham DL; Latino FA; Payne SE
    J Nucl Med; 1994 Feb; 35(2):349-55. PubMed ID: 8295009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identity confirmation of 99mTc-MAG3, 99mTc-sestamibi and 99mTc-ECD using radio-LC-MS.
    Verduyckt T; Kieffer D; Huyghe D; Cleynhens B; Verbeke K; Verbruggen A; Bormans G
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):669-78. PubMed ID: 12899957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules.
    Wang Y; Liu G; Hnatowich DJ
    Nat Protoc; 2006; 1(3):1477-80. PubMed ID: 17406438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of alternative methods of preparing 99mTc-MAG3.
    Seetharaman S; Sosabowski MH; Ballinger JR
    Appl Radiat Isot; 2007 Nov; 65(11):1240-3. PubMed ID: 17434313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tc-99m DMSA and Tc-99m MAG3 findings in crossed renal ectopia.
    Jiménez-Heffernan A; Rebollo AC; Garcia-Martin M; Herrera C; Acosta J
    Clin Nucl Med; 1998 Apr; 23(4):255. PubMed ID: 9554207
    [No Abstract]   [Full Text] [Related]  

  • 36. A simple method for determining split renal function from dynamic (99m)Tc-MAG3 scintigraphic data.
    Wesolowski MJ; Conrad GR; Šámal M; Watson G; Wanasundara SN; Babyn P; Wesolowski CA
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):550-8. PubMed ID: 26537286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of four technetium-99m radiopharmaceuticals for detection and localization of gastrointestinal bleeding in a sheep model.
    Owunwanne A; Al-Wafai I; Vallgren S; Sadek S; Abdel-Dayem HM; Yacoub T
    Am J Physiol Imaging; 1988; 3(4):192-6. PubMed ID: 2975183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid quality control for testing the radiochemical purity of 99Tc(m)-tetrofosmin.
    Métayé T; Desmarquet M; Rosenberg T; Guilhot J; Bouin-Pineau MH
    Nucl Med Commun; 2001 Oct; 22(10):1139-44. PubMed ID: 11567189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extrarenal collection of Tc-99m MAG3 mimicking a urinary leak in a patient who underwent partial nephrectomy.
    Suga K; Kume N; Hirabayashi A; Kishimoto K; Matsunaga N
    Clin Nucl Med; 1998 Aug; 23(8):546-7. PubMed ID: 9712398
    [No Abstract]   [Full Text] [Related]  

  • 40. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
    Zhang YR; Zhang YX; Cao W; Lan XL
    J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.